Researchers gathered data from the Taiwan National Health Insurance Research Database. They studied 13,787 patients with dengue newly diagnosed between 2000 and 2012. They matched the dengue patients to a control cohort of patients who did not have dengue by demographic characteristics and stroke-related comorbidities.
The study shows the overall incidence rate of stroke was 5.33 per 1000 person-years in the dengue cohort and 3.72 per 1000 person-years in the control cohort. The risk of stroke among patients with dengue was highest in the first two months after diagnosis.
“The effect of dengue on stroke may be acute rather than chronic,” study authors noted.
More articles on healthcare quality:
Viewpoint: How physicians can compassionately pronounce patient’s death
Wisconsin nurse under investigation for injuries to babies allegedly fired by UW hospital
WSJ report spurs House oversight of hospital accreditation processes
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
